ArticleSensors (Basel, Switzerland)2024
A Multi-Scale Liver Tumor Segmentation Method Based on Residual and Hybrid Attention Enhanced Network with Contextual Integration.
Article in Sensors (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- RIS-UNet: A Multi-Level Hierarchical Framework for Liver Tumor Segmentation in CT Images.Entropy (Basel, Switzerland) · 2025Article
- Multi-Scale Convolutional Attention and Structural Re-Parameterized Residual-Based 3D U-Net for Liver and Liver Tumor Segmentation from CT.Sensors (Basel, Switzerland) · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Liver cancer is one of the malignancies with high mortality rates worldwide, and its timely detection and accurate diagnosis are crucial for improving patient prognosis. To address the limitations of traditional image segmentation techniques and the U-Net network in capturing fine image features, this study proposes an improved model based on the U-Net architecture, named RHEU-Net. By replacing traditional convolution modules in the encoder and decoder with improved residual modules, the network's feature extraction capabilities and gradient stability are enhanced. A Hybrid Gated Attention (HGA) module is integrated before the skip connections, enabling the parallel processing of channel and spatial attentions, optimizing the feature fusion strategy, and effectively replenishing image details. A Multi-Scale Feature Enhancement (MSFE) layer is introduced at the bottleneck, utilizing multi-scale feature extraction technology to further enhance the expression of receptive fields and contextual information, improving the overall feature representation effect. Testing on the LiTS2017 dataset demonstrated that RHEU-Net achieved Dice scores of 95.72% for liver segmentation and 70.19% for tumor segmentation. These results validate the effectiveness of RHEU-Net and underscore its potential for clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.